Jahan Rahman

8PUBLICATIONS
120CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2026
Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors.

|Mar 18, 2026
A post-translational regulatory map of chronic antigen-driven human T cell dysfunction.

Hiroyuki Kojima, Charlotte R Wayne, Luis F Somarribas Patterson

|Aug 11, 2025
Systematic Evaluation of GAPs and GEFs Identifies a Targetable Dependency for Hematopoietic Malignancies.

Pu Zhang, Zhendong Cao, Xiangyu Pan

|Nov 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

|Jul 03, 2024
Augmenting CAR T-cell Functions with LIGHT.

Winson Cai, Kento Tanaka, Xiaoli Mi

|Jun 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

Pageof 2

Frequent Collaborators

4 joint publications

Omar Abdel-Wahab

3 joint publications

Santosha A Vardhana

2 joint publications

Esther Drill

2 joint publications

Ekaterina Postovalova